Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Get trade alerts by text
We text you when insiders, Congress or big funds make new trades. Free.
Barclays Reiterates Overweight Rating on PPL Corporation
Barclays maintains its Overweight rating on PPL Corporation with a new target of $38, while shares are currently below that level.
Barclays Reiterates Overweight Rating on Qnity Electronics, Inc.
Barclays maintains its bullish stance on Qnity Electronics with a target of $211.00.
Truist Securities Reiterates Buy Rating on Qnity Electronics
Truist Securities has reaffirmed its Buy rating on Qnity Electronics and set a price target of $170.
RBC Capital Reiterates Outperform Rating on Qnity Electronics
RBC Capital keeps a positive outlook on Qnity Electronics while adjusting its price target.
Truist Securities Maintains Buy Rating on CenterPoint Energy
Truist Securities reaffirms its Buy rating on CenterPoint Energy with a new price target of $44.00.
Keybanc Reiterates Overweight Rating on CenterPoint Energy
Keybanc maintains its Overweight rating on CenterPoint Energy with a price target of $44.00.
Citigroup Reiterates Buy Rating on Xylem Inc.
Citigroup has reaffirmed its Buy rating on Xylem, adjusting its price target to $148.0.
Barclays Reiterates Overweight Rating on Xylem Inc.
Barclays has maintained its Overweight rating on Xylem Inc. with a new price target of $139.0.
RBC Capital Reiterates Outperform Rating on Xylem Inc.
RBC Capital has reiterated its Outperform rating on Xylem with a revised price target of $135.0 as of October 14, 2026.
Oppenheimer Reiterates Outperform Rating on Xylem Inc.
Oppenheimer has reaffirmed its Outperform rating on Xylem with a price target of $150.
Mizuho Reiterates Outperform Rating on Dover Corporation
Mizuho maintains its Outperform rating and adjusts the price target for Dover Corporation to $245.
HC Wainwright Reiterates Buy Rating on Incyte Corporation
HC Wainwright has reiterated its Buy rating on Incyte Corporation with a price target of $152 as of October 13, 2026.
TD Cowen Maintains Buy Rating on West Pharmaceutical Services, Inc.
TD Cowen has reiterated its Buy rating for West Pharmaceutical Services with a new price target of $420.
Wells Fargo Maintains Underweight Rating on W. R. Berkley Corporation
Wells Fargo has reiterated its Underweight rating on W. R. Berkley, lowering the price target to $65.
Goldman Sachs Maintains Buy Rating on Affirm Holdings
Goldman Sachs has reaffirmed its Buy rating on Affirm Holdings, lowering the price target to $103.
Citigroup Reiterates Buy Rating on nVent Electric plc
Citigroup has maintained its Buy rating on nVent Electric, raising the price target to $228 on October 12, 2026.
RBC Capital Reiterates Outperform Rating on nVent Electric plc
RBC Capital has reiterated its Outperform rating on nVent Electric plc with a new price target of $208.
RBC Capital Reiterates Outperform Rating on F5, Inc.
RBC Capital maintains its Outperform rating on F5, Inc. with a new price target of $525.
Barclays Reiterates Overweight Rating on FirstEnergy Corp.
Barclays has reiterated its Overweight rating on FirstEnergy Corp., adjusting its price target to $49 from $54.
Barclays Reiterates Overweight Rating on Las Vegas Sands Corp.
Barclays has reaffirmed its Overweight rating on Las Vegas Sands Corp. with a new price target of $57.0.
Goldman Sachs Reiterates Buy Rating on Las Vegas Sands Corp.
Goldman Sachs has maintained its Buy rating on Las Vegas Sands Corp. with a new price target of $47.
Morgan Stanley Reiterates Overweight Rating on LPL Financial Holdings
Morgan Stanley has increased its price target for LPL Financial Holdings to $393.00.
Truist Securities Maintains Buy Rating on DTE Energy Company
Truist Securities reiterates its Buy rating for DTE Energy with a target price adjustment to $150.
HC Wainwright Reiterates Buy Rating on Insmed Incorporated
HC Wainwright has reiterated its Buy rating on Insmed with a price target of $220 as of October 12, 2026.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.